Xiaodong Wang - 24 Jun 2025 Form 4 Insider Report for BeOne Medicines Ltd. (ONC)

Reporting relationship: Director, Chair, Scientific Advisory Brd
Issuer ticker: ONC
Reported as of: 24 Jun 2025
Net transaction value: -$532,867
SEC form: 4
Accepted by SEC: 25 Jun 2025, 17:08:08 UTC
Prior SEC filing: 12 Jun 2025
Next SEC filing: 11 Sep 2025
Source filing: View source filing
Reporting owner signature: /s/ Qing Nian, as Attorney-in-Fact

Key filing fact

Xiaodong Wang filed Form 4 for BeOne Medicines Ltd. (ONC) on 25 Jun 2025.

Key facts

This page summarizes Xiaodong Wang's Form 4 filing for BeOne Medicines Ltd. (ONC).
4 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 25 Jun 2025, 17:08.

Change

Previous filing in this sequence was filed on 12 Jun 2025.
Current net transaction value: -$532,867.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001662982 Primary reporting owner

Wang Xiaodong

Relationship: Director, Chair, Scientific Advisory Brd
Address: C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, SWITZERLAND
Signature: /s/ Qing Nian, as Attorney-in-Fact
Signature date: 25 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ONC transaction

American Depositary Shares

Sale

Transaction value: $79,050
Shares: -300
Change %: -15%
Price: $263.50
Shares after: 1,707
Date: 24 Jun 2025
Ownership: Direct
Footnotes: F4, F5, F6

ONC transaction

American Depositary Shares

Sale

Transaction value: $291,888
Shares: -1,100
Change %: -64%
Price: $265.35
Shares after: 607
Date: 24 Jun 2025
Ownership: Direct
Footnotes: F4, F5, F7

ONC transaction

American Depositary Shares

Sale

Transaction value: $135,149
Shares: -507
Change %: -84%
Price: $266.57
Shares after: 100
Date: 24 Jun 2025
Ownership: Direct
Footnotes: F4, F5, F8

ONC transaction

American Depositary Shares

Sale

Transaction value: $26,781
Shares: -100
Change %: -100%
Price: $267.81
Shares after: 0
Date: 24 Jun 2025
Ownership: Direct
Footnotes: F4, F5

ONC holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 5,154,770
Date: 24 Jun 2025
Ownership: Direct

ONC holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,025,063
Date: 24 Jun 2025
Ownership: See Footnote
Footnotes: F1

ONC holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 3,953,100
Date: 24 Jun 2025
Ownership: See Footnote
Footnotes: F2

ONC holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 50
Date: 24 Jun 2025
Ownership: See Footnote
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 8 footnotes

Footnote F1

These securities are held by a family trust, the beneficiaries of which are the Reporting Person's family members, for which the Reporting Person disclaims beneficial ownership.

Footnote F2

These securities are held by Wang Investment LLC, of which 99% of the limited liability company interest is owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership.

Footnote F3

These securities are held by the spouse of the Reporting Person.

Footnote F4

Each American Depositary Share represents 13 Ordinary Shares.

Footnote F5

The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on August 12, 2024.

Footnote F6

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $263.40 to $263.55, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Footnote F7

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $265.02 to $265.86, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Footnote F8

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $266.27 to $266.95, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.